Japanese Minister Says PMDA Not Excluded From Streamlining Review
This article was originally published in PharmAsia News
Executive SummaryMinister of Administrative Reform Sachio Edano said the nation's pharmaceutical review body - the Pharmaceutical and Medical Device Agency - will be subject to a streamlining review. Edano didn't pinpoint problems within the PMDA, yet said that all administrative agencies are subject to such a review. The minister made the statement during an interview with online journalists. (Click here for more - Japanese language
You may also be interested in...
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.